Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.84 NOK Market Closed
Market Cap: 726.9m NOK
Have any thoughts about
Hofseth Biocare ASA?
Write Note

Intrinsic Value

HBC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one HBC stock under the Base Case scenario is 4.17 NOK. Compared to the current market price of 1.84 NOK, Hofseth Biocare ASA is Undervalued by 56%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HBC Intrinsic Value
4.17 NOK
Undervaluation 56%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Hofseth Biocare ASA

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for HBC cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about HBC?
Bearish
Neutral
Bullish

Fundamental Analysis

1.84 NOK
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Hofseth Biocare ASA
NO
Biotechnology
Market Cap
756.4m NOK
IPO
Dec 2, 2011
Employees
63
Norway
Market Cap
756.4m NOK
Industry
Biotechnology
IPO
Dec 2, 2011
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Hofseth Biocare ASA

Provide an overview of the primary business activities
of Hofseth Biocare ASA.

What unique competitive advantages
does Hofseth Biocare ASA hold over its rivals?

What risks and challenges
does Hofseth Biocare ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hofseth Biocare ASA.

Provide P/S
for Hofseth Biocare ASA.

Provide P/E
for Hofseth Biocare ASA.

Provide P/OCF
for Hofseth Biocare ASA.

Provide P/FCFE
for Hofseth Biocare ASA.

Provide P/B
for Hofseth Biocare ASA.

Provide EV/S
for Hofseth Biocare ASA.

Provide EV/GP
for Hofseth Biocare ASA.

Provide EV/EBITDA
for Hofseth Biocare ASA.

Provide EV/EBIT
for Hofseth Biocare ASA.

Provide EV/OCF
for Hofseth Biocare ASA.

Provide EV/FCFF
for Hofseth Biocare ASA.

Provide EV/IC
for Hofseth Biocare ASA.

What are the Revenue projections
for Hofseth Biocare ASA?

How accurate were the past Revenue estimates
for Hofseth Biocare ASA?

What are the Net Income projections
for Hofseth Biocare ASA?

How accurate were the past Net Income estimates
for Hofseth Biocare ASA?

What are the EPS projections
for Hofseth Biocare ASA?

How accurate were the past EPS estimates
for Hofseth Biocare ASA?

What are the EBIT projections
for Hofseth Biocare ASA?

How accurate were the past EBIT estimates
for Hofseth Biocare ASA?

Compare the revenue forecasts
for Hofseth Biocare ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hofseth Biocare ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hofseth Biocare ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hofseth Biocare ASA compared to its peers.

Compare the P/E ratios
of Hofseth Biocare ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Hofseth Biocare ASA with its peers.

Analyze the financial leverage
of Hofseth Biocare ASA compared to its main competitors.

Show all profitability ratios
for Hofseth Biocare ASA.

Provide ROE
for Hofseth Biocare ASA.

Provide ROA
for Hofseth Biocare ASA.

Provide ROIC
for Hofseth Biocare ASA.

Provide ROCE
for Hofseth Biocare ASA.

Provide Gross Margin
for Hofseth Biocare ASA.

Provide Operating Margin
for Hofseth Biocare ASA.

Provide Net Margin
for Hofseth Biocare ASA.

Provide FCF Margin
for Hofseth Biocare ASA.

Show all solvency ratios
for Hofseth Biocare ASA.

Provide D/E Ratio
for Hofseth Biocare ASA.

Provide D/A Ratio
for Hofseth Biocare ASA.

Provide Interest Coverage Ratio
for Hofseth Biocare ASA.

Provide Altman Z-Score Ratio
for Hofseth Biocare ASA.

Provide Quick Ratio
for Hofseth Biocare ASA.

Provide Current Ratio
for Hofseth Biocare ASA.

Provide Cash Ratio
for Hofseth Biocare ASA.

What is the historical Revenue growth
over the last 5 years for Hofseth Biocare ASA?

What is the historical Net Income growth
over the last 5 years for Hofseth Biocare ASA?

What is the current Free Cash Flow
of Hofseth Biocare ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hofseth Biocare ASA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hofseth Biocare ASA

Current Assets 125.3m
Cash & Short-Term Investments 23.4m
Receivables 28.8m
Other Current Assets 73.2m
Non-Current Assets 240m
Long-Term Investments 50.1m
PP&E 145.6m
Intangibles 44.3m
Other Non-Current Assets 1k
Current Liabilities 172.5m
Accounts Payable 66.7m
Other Current Liabilities 105.8m
Non-Current Liabilities 89.1m
Long-Term Debt 89.7m
Other Non-Current Liabilities -687k
Efficiency

Earnings Waterfall
Hofseth Biocare ASA

Revenue
239.9m NOK
Cost of Revenue
-173.4m NOK
Gross Profit
66.5m NOK
Operating Expenses
-192.3m NOK
Operating Income
-125.8m NOK
Other Expenses
-7.7m NOK
Net Income
-133.5m NOK

Free Cash Flow Analysis
Hofseth Biocare ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

HBC Profitability Score
Profitability Due Diligence

Hofseth Biocare ASA's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive 1-Year Revenue Growth
Declining ROIC
22/100
Profitability
Score

Hofseth Biocare ASA's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

HBC Solvency Score
Solvency Due Diligence

Hofseth Biocare ASA's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
30/100
Solvency
Score

Hofseth Biocare ASA's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HBC Price Targets Summary
Hofseth Biocare ASA

There are no price targets for HBC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HBC?

Click here to dive deeper.

Dividends

Hofseth Biocare ASA
does not pay dividends
Shareholder Yield

Current shareholder yield for HBC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one HBC stock?

The intrinsic value of one HBC stock under the Base Case scenario is 4.17 NOK.

Is HBC stock undervalued or overvalued?

Compared to the current market price of 1.84 NOK, Hofseth Biocare ASA is Undervalued by 56%.

Back to Top